BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6108369)

  • 1. The use of monoclonal antibodies in the study of lactose-sensitive adherence of Actinomyces viscosus T14V.
    Cisar JO; Barsumian EL; Curl SH; Vatter AE; Sandberg AL; Siraganian RP
    J Reticuloendothel Soc; 1980 Dec; 28(Suppl):73s-79s. PubMed ID: 6108369
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection and localization of a lectin on Actinomyces viscosus T14V by monoclonal antibodies.
    Cisar JO; Barsumian EL; Curl SH; Vatter AE; Sandberg AL; Siraganian RP
    J Immunol; 1981 Oct; 127(4):1318-22. PubMed ID: 6115881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.
    Revis GJ; Vatter AE; Crowle AJ; Cisar JO
    Infect Immun; 1982 Jun; 36(3):1217-22. PubMed ID: 6124506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of bacterial adhesion in the oral cavity.
    Mergenhagen SE; Sandberg AL; Chassy BM; Brennan MJ; Yeung MK; Donkersloot JA; Cisar JO
    Rev Infect Dis; 1987; 9 Suppl 5():S467-74. PubMed ID: 2891180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of in vitro attachment of Streptococcus sanguis and Actinomyces viscosus to saliva-treated titanium.
    Wolinsky LE; de Camargo PM; Erard JC; Newman MG
    Int J Oral Maxillofac Implants; 1989; 4(1):27-31. PubMed ID: 2599579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.
    Cisar JO; David VA; Curl SH; Vatter AE
    Infect Immun; 1984 Nov; 46(2):453-8. PubMed ID: 6150007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lactose-reversible adherence between Actinomyces viscosus and oral streptococci by salivary components.
    Komiyama K; Gibbons RJ
    Caries Res; 1984; 18(3):193-200. PubMed ID: 6584210
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitors of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34: beta-galactosides, related sugars, and anionic amphipathic compounds.
    McIntire FC; Crosby LK; Vatter AE
    Infect Immun; 1982 Apr; 36(1):371-8. PubMed ID: 7076303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fimbriae of Actinomyces viscosus t14v: their relationship to the virulence-associated antigen and to coaggregation with Streptococcus sanguis 34.
    Cisar JO; McIntire FC; Vatter AE
    Adv Exp Med Biol; 1978; 107():695-701. PubMed ID: 84522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of coaggregation-defective mutants of Actinomyces viscosus, Actinomyces naeslundii, and Streptococcus sanguis.
    Kolenbrander PE
    Infect Immun; 1982 Sep; 37(3):1200-8. PubMed ID: 7129635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function and distribution of different fimbriae on strains of Actinomyces viscosus and Actinomyces naeslundii.
    Cisar JO; Sandberg AL; Mergenhagen SE
    J Dent Res; 1984 Mar; 63(3):393-6. PubMed ID: 6142065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant low responsiveness in the IgG response of mice to the complex protein antigen type 1 fimbriae from Actinomyces viscosus T14V.
    Haber J; Paradis G; Grinnell CM
    J Immunol; 1991 Mar; 146(6):1949-54. PubMed ID: 1672336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific absence of type 2 fimbriae on a coaggregation-defective mutant of Actinomyces viscosus T14V.
    Cisar JO; Curl SH; Kolenbrander PE; Vatter AE
    Infect Immun; 1983 May; 40(2):759-65. PubMed ID: 6132880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on biological properties of fimbriae of A. viscosus. III. Adherence activity of fimbriae of A. viscosus].
    Liu T; Li W; Yue S
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 May; 17(2):169-72. PubMed ID: 12539718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1.
    Mizuno J; Cisar JO; Vatter AE; Fennessey PV; McIntire FC
    Infect Immun; 1983 Jun; 40(3):1204-13. PubMed ID: 6303957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of bacterial interactions in the colonization of oral surfaces of Actinomyces viscosus.
    Kuramitsu HK; Paul A
    Infect Immun; 1980 Jul; 29(1):83-90. PubMed ID: 6772577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34.
    McIntire FC; Vatter AE; Baros J; Arnold J
    Infect Immun; 1978 Sep; 21(3):978-88. PubMed ID: 30701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polysaccharide from Streptococcus sanguis 34 that inhibits coaggregation of S. sanguis 34 with Actinomyces viscosus T14V.
    McIntire FC; Crosby LK; Vatter AE; Cisar JO; McNeil MR; Bush CA; Tjoa SS; Fennessey PV
    J Bacteriol; 1988 May; 170(5):2229-35. PubMed ID: 3360742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces.
    Clark WB; Webb EL; Wheeler TT; Fischlschweiger W; Birdsell DC; Mansheim BJ
    Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical and functional studies of Actinomyces viscosus T14V type 1 fimbriae with monoclonal and polyclonal antibodies directed against the fimbrial subunit.
    Cisar JO; Barsumian EL; Siraganian RP; Clark WB; Yeung MK; Hsu SD; Curl SH; Vatter AE; Sandberg AL
    J Gen Microbiol; 1991 Aug; 137(8):1971-9. PubMed ID: 1683401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.